Active pharmaceutical ingredient , or API, is basically the component within any prescribed drug that releases its effect on the human body. Every drug that is developed carries two core components, the API and the excipients, which are the chemically inactive parts of the drug. The expected high potency APIs market valuation stands at 26.6 billion with a projected CAGR of 8.40% over the forecast period of 2017 to 2023. Targeted therapy is one of the latest methods of dealing with ailments that make use of high potency APIs. Progresses of health awareness concept amongst developing nations such as India, China, and others have also led to the market growth of high potency APIs. The market is primarily driven by the number of investments undertaken by companies in the high potency APIs. Various tests are conducted to determine the API level of a drug and every pharmaceutical company must make their API levels known to the FDA. Request a FREE Sample ...